Seelos Therapeutics, Inc.

SEEL · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$2,996$15,533$78,734$15,662
Short-Term Investments$0$0$0$0
Receivables$763$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,644$7,141$4,727$1,832
Total Curr. Assets$5,403$22,674$83,461$17,494
Property Plant & Equip (Net)$15$72$39$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0-$72-$39$0
Total NC Assets$15$72$39$0
Other Assets$0$0$0$0
Total Assets$5,418$22,746$83,500$17,494
Liabilities
Payables$16,403$3,626$1,693$1,887
Short-Term Debt$14,228$11,981$1,106$2,431
Tax Payable$0$0$0$0
Deferred Revenue$0$0$3,928$2,049
Other Curr. Liab.$8,297$9,551$5,488$3,111
Total Curr. Liab.$38,928$25,158$8,287$7,429
LT Debt$0$8,199$17,890$7,293
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$200
Total NC Liab.$0$8,199$17,890$7,493
Other Liabilities$0$0$0$0
Cap. Leases$15$73$38$0
Total Liabilities$38,928$33,357$26,177$14,922
Equity
Pref Stock$0$0$0$0
Common Stock$10$107$105$54
Retained Earnings-$252,626-$214,744-$141,210-$75,162
AOCI$0$0$0$0
Other Equity$219,106$204,026$198,428$77,680
Total Equity-$33,510-$10,611$57,323$2,572
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,418$22,746$83,500$17,494
Net Debt$11,232$4,647-$59,738-$5,938
Seelos Therapeutics, Inc. (SEEL) Financial Statements & Key Stats | AlphaPilot